Soluble IL-2Rα correlates with imbalances of Th1/Th2 and Tc1/Tc2 cells in patients with acute brucellosis

Background Previous studies showed that soluble IL-2Rα is an important marker of cellular immune activation and might be a marker of treatment efficacy for children with brucellosis. However, data regarding adult patients with brucellosis were unknown. The aim of study was to explore the potential role of serum sIL-2Rα evaluating treatment responses in adult patients with brucellosis, and T cell immune status was also examined. Methods During January 2016–April 2017, 30 patients with acute brucellosis from the Third People’s Hospital of Linfen in Shanxi Province and Beijing Di Tan Hospital, and 28 healthy controls were included in this study. Peripheral blood samples were collected before and after six weeks of antibiotic treatment. Serum sIL-2Rα levels were measured by enzyme-linked immunosorbent assay, and the percentage of Th1, Th2, Tc1, Tc2, and Tregs was detected by flow cytometry after intracellular staining for cytokines (interferon-γ and interleukin-4) and Foxp3 in T lymphocytes from peripheral blood. The obtained data were analyzed with Wilcoxon ranked sum tests for paired values, Mann-Whitney U-tests for comparisons between patients and healthy controls, and Spearman rank tests for correlation analyses. Results Serum sIL-2Rα levels were significantly higher in patients than in controls ( P  = 0.001). A significant decline was observed in patients after the cessation of treatment ( P  < 0.001) and return to normal ( P  > 0.05). Th1, Tc1, Th2, and Tc2 cell frequencies were higher in patients than in healthy subjects ( P  < 0.05), while the Th1/Th2 and Tc1/Tc2 ratios were significantly lower ( P  = 0.0305 and 0.0005, respectively) and returned to normal levels after treatment. In patients with acute brucellosis, serum sIL-2Rα levels were negatively correlated with the Th1/Th2 ratio ( r  = − 0.478, P  = 0.028), Tc1/Tc2 ratio ( r  = − 0.677, P  = 0.001), and Tc1 percentage ( r  = − 0.516, P  = 0.017). Serum sIL-2Rα and Tc2 percentages were positively correlated ( r  = 0.442, P  = 0.045). Conclusions Based on the correlations with Th1/Th2 and Tc1/Tc2 ratios, serum sIL-2Rα levels may reflect the immune response status. sIL-2Rα may be a marker for therapeutic efficacy in acute brucellosis.

[1]  Georgios Pappas,et al.  The new global map of human brucellosis. , 2006, The Lancet. Infectious diseases.

[2]  D. Gemsa,et al.  Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes , 2003, Journal of leukocyte biology.

[3]  U. Olsson‐Strömberg,et al.  T regulatory cells control T‐cell proliferation partly by the release of soluble CD25 in patients with B‐cell malignancies , 2010, Immunology.

[4]  Werner Müller,et al.  CD4+ T Cell-derived IL-10 Promotes Brucella abortus Persistence via Modulation of Macrophage Function , 2013, PLoS pathogens.

[5]  S. Ansell,et al.  Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma. , 2011, Blood.

[6]  W. Greene,et al.  The molecular basis for the generation of the human soluble interleukin 2 receptor. , 1990, Cytokine.

[7]  F. Annunziato,et al.  The 3 major types of innate and adaptive cell-mediated effector immunity. , 2015, The Journal of allergy and clinical immunology.

[8]  A. Kariminia,et al.  Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. , 2006, The Journal of infection.

[9]  E. Hatzimichael,et al.  Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis. , 2005, The Journal of infection.

[10]  M. Delpino,et al.  Brucella abortus induces intracellular retention of MHC‐I molecules in human macrophages down‐modulating cytotoxic CD8+ T cell responses , 2013, Cellular microbiology.

[11]  Xing-wang Li,et al.  Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosis. , 2019, Journal of infection in developing countries.

[12]  G. Izbicki,et al.  Role of Soluble Interleukin-2 Receptor Levels in Patients with Latent Tuberculosis , 2005, Lung.

[13]  E. Shevach,et al.  CD4+CD25+ T regulatory cells limit effector T cells and favor the progression of brucellosis in BALB/c mice. , 2010, Microbes and infection.

[14]  E. Ayaşlıoğlu,et al.  Significant elevation of serum soluble CD14 levels in patients with brucellosis. , 2005, Japanese journal of infectious diseases.

[15]  S. Ebrahimpour,et al.  Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis. , 2016, Journal of Biological Regulators and Homeostatic Agents.

[16]  J. Sprent,et al.  The role of interleukin-2 during homeostasis and activation of the immune system , 2012, Nature Reviews Immunology.

[17]  D. Scott,et al.  Ontogeny of Th1 Memory Responses against a Brucella abortus Conjugate , 2001, Infection and Immunity.

[18]  G. Splitter,et al.  CD8+ T Cell Exhaustion, Suppressed Gamma Interferon Production, and Delayed Memory Response Induced by Chronic Brucella melitensis Infection , 2015, Infection and Immunity.

[19]  M. D’Elios,et al.  Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo , 2002, European journal of immunology.

[20]  T. Šarić,et al.  CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. , 2006, Blood.

[21]  G. Splitter,et al.  Active Evasion of CTL Mediated Killing and Low Quality Responding CD8+ T Cells Contribute to Persistence of Brucellosis , 2012, PloS one.

[22]  C. Guzmán-Verri,et al.  Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of Infection , 2007, PloS one.

[23]  L. Fernandez-Herlihy,et al.  Human brucellosis. , 1959, The Lahey Clinic bulletin.

[24]  R. Tsolis,et al.  Brucella spp. Virulence Factors and Immunity. , 2016, Annual review of animal biosciences.

[25]  C. Baldwin,et al.  Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. , 2002, Veterinary microbiology.

[26]  P. Elzer,et al.  B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus. , 2011, The Journal of infectious diseases.

[27]  G. Pappas,et al.  Cell-mediated immunity in human brucellosis. , 2011, Microbes and infection.

[28]  P. de Figueiredo,et al.  Pathogenesis and Immunobiology of Brucellosis Review of Brucella e Host Interactions 80 81 , 2015 .

[29]  A. De La Hera,et al.  Human Brucellosis Is Characterized by an Intense Th1 Profile Associated with a Defective Monocyte Function , 2010, Infection and Immunity.

[30]  R. Gilman,et al.  Human brucellosis. , 2007, The Lancet. Infectious diseases.

[31]  K. Bourantas,et al.  Interleukin-3 and Interleukin-4 in Childhood Brucellosis , 2002, Infection.

[32]  J. Todd,et al.  Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients , 2013, Diabetologia.

[33]  H. Oral,et al.  Diagnostic value of serum concentrations of high‐mobility group‐box protein 1 and soluble hemoglobin scavenger receptor in brucellosis , 2013, Microbiology and immunology.

[34]  A. Baryshnikov,et al.  Serum levels of soluble HLA and IL-2R molecules in patients with urogenital chlamydia infection. , 2007, Advances in experimental medicine and biology.

[35]  M. Atkinson,et al.  Hepatocellular Carcinoma Immunopathogenesis: Clinical Evidence for Global T Cell Defects and an Immunomodulatory Role for Soluble CD25 (sCD25) , 2010, Digestive Diseases and Sciences.

[36]  H. Bibi,et al.  Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. , 2007, The Israel Medical Association journal : IMAJ.